SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $557,000 | +19.0% | 3,268 | -2.0% | 0.01% | 0.0% |
| Q3 2020 | $468,000 | -15.2% | 3,333 | -3.1% | 0.01% | -14.3% |
| Q2 2020 | $552,000 | +6.2% | 3,440 | -35.2% | 0.01% | -22.2% |
| Q1 2020 | $520,000 | +53.4% | 5,311 | +138.2% | 0.01% | +80.0% |
| Q2 2019 | $339,000 | +37.8% | 2,230 | +8.1% | 0.01% | +25.0% |
| Q1 2019 | $246,000 | +22.4% | 2,063 | +12.1% | 0.00% | 0.0% |
| Q4 2018 | $201,000 | -42.9% | 1,840 | -15.6% | 0.00% | -33.3% |
| Q3 2018 | $352,000 | +41.9% | 2,179 | +15.9% | 0.01% | +20.0% |
| Q2 2018 | $248,000 | +22.2% | 1,880 | -31.5% | 0.01% | +25.0% |
| Q1 2018 | $203,000 | -59.6% | 2,744 | -69.6% | 0.00% | -60.0% |
| Q4 2017 | $502,000 | +6.4% | 9,026 | -13.3% | 0.01% | 0.0% |
| Q3 2017 | $472,000 | +72.9% | 10,409 | +28.3% | 0.01% | +100.0% |
| Q2 2017 | $273,000 | – | 8,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |